Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-frequency Atripla maintenance in virologically suppressed adults with HIV-1
2012-004970-24Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of tenofovir disoproxil fumarate in Human immunodeficiency virus infection type 1, sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Proportion maintaining standard plasma viral load suppression at 24 weeks. Started Apr 2013; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2012-004970-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004970-24.